Purple Biotech Ltd. Sponsored ADR (PPBT)

Last Closing Price: 0.67 (2024-03-28)

Company Description

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-19.88M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.45
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -57.40%
Return on Assets (Trailing 12 Months) -49.02%
Current Ratio (Most Recent Fiscal Quarter) 2.20
Quick Ratio (Most Recent Fiscal Quarter) 2.20
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $1.36
Earnings per Share (Most Recent Fiscal Quarter) $-0.32
Earnings per Share (Most Recent Fiscal Year) $-1.09
Diluted Earnings per Share (Trailing 12 Months) $-0.92
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 25.24M
Free Float 24.49M
Market Capitalization $15.42M
Average Volume (Last 20 Days) 0.11M
Beta (Past 60 Months) 0.97
Percentage Held By Insiders (Latest Annual Proxy Report) 2.98%
Percentage Held By Institutions (Latest 13F Reports) 9.64%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%